Previous Close | 18.00 |
Open | 19.95 |
Bid | 0.00 |
Ask | 0.00 |
Strike | 145.00 |
Expire Date | 2025-01-17 |
Day's Range | 18.00 - 19.95 |
Contract Range | N/A |
Volume | |
Open Interest | 475 |
Center for Biologics Evaluation and Research has chosen mRNA-3705 as one of four investigational medicines for accelerated development to address unmet medical needs for rare diseases CAMBRIDGE, MA / ACCESSWIRE / June 6, 2024 / Moderna, Inc. (NASDAQ:MRNA) ...
An FDA panel meeting is scheduled on Jun 5 to consider if COVID-19 vaccines should be updated to target the WHO-recommended JN.1 variant or the KP.2 variant which is the currently dominating strain in the country.